Cardinal Capital Management Has $855,000 Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Cardinal Capital Management raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 5.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,345 shares of the company’s stock after purchasing an additional 670 shares during the quarter. Cardinal Capital Management’s holdings in Henry Schein were worth $855,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Beach Investment Counsel Inc. PA bought a new position in shares of Henry Schein in the second quarter worth $37,000. Mather Group LLC. increased its position in shares of Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after purchasing an additional 216 shares during the period. Palisade Asset Management LLC bought a new position in shares of Henry Schein in the first quarter worth $113,000. Benjamin F. Edwards & Company Inc. increased its position in shares of Henry Schein by 37.8% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after purchasing an additional 416 shares during the period. Finally, Covestor Ltd increased its position in shares of Henry Schein by 12.8% in the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after purchasing an additional 171 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

HSIC has been the topic of a number of recent analyst reports. Piper Sandler reiterated an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research report on Friday, June 21st. Evercore ISI cut their price target on Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research note on Wednesday. Robert W. Baird cut their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday. UBS Group cut their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday. Finally, Barrington Research cut their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $77.90.

Henry Schein Trading Up 1.1 %

HSIC stock traded up $0.78 during trading on Friday, hitting $68.94. 2,399,686 shares of the company traded hands, compared to its average volume of 1,227,769. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. The company has a 50-day moving average of $67.73 and a 200-day moving average of $71.55. The firm has a market capitalization of $8.83 billion, a PE ratio of 23.29, a P/E/G ratio of 1.80 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The company had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm’s revenue for the quarter was up .0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. Analysts predict that Henry Schein, Inc. will post 5.16 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.